These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28717852)

  • 21. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
    Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
    J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
    Parris TZ; Kovács A; Aziz L; Hajizadeh S; Nemes S; Semaan M; Forssell-Aronsson E; Karlsson P; Helou K
    Int J Cancer; 2014 Apr; 134(7):1617-29. PubMed ID: 24114735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic stromal gene signatures in breast cancer.
    Winslow S; Leandersson K; Edsjö A; Larsson C
    Breast Cancer Res; 2015 Feb; 17(1):23. PubMed ID: 25848820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast.
    Arai K; Takano S; Teratani T; Ito Y; Yamada T; Nozawa R
    Curr Cancer Drug Targets; 2008 Jun; 8(4):243-52. PubMed ID: 18537548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
    Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
    Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
    Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
    Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients.
    Al-Ansari MM; Al-Saif M; Arafah M; Eldali AM; Tulbah A; Al-Tweigeri T; Semlali A; Khabar KS; Aboussekhra A
    Breast Cancer Res; 2020 May; 22(1):49. PubMed ID: 32414408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3224-34. PubMed ID: 25031743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
    Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
    Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
    Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer.
    Ali HR; Dawson SJ; Blows FM; Provenzano E; Leung S; Nielsen T; Pharoah PD; Caldas C
    J Pathol; 2012 Jan; 226(1):97-107. PubMed ID: 21953021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
    Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
    Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic phenotypes in triple-negative breast cancer.
    Kim S; Kim DH; Jung WH; Koo JS
    Tumour Biol; 2013 Jun; 34(3):1699-712. PubMed ID: 23443971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status.
    Chung YR; Kim HJ; Jang MH; Park SY
    Breast Cancer Res Treat; 2017 Feb; 161(3):409-420. PubMed ID: 27913931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L1 expression and tumor infiltrating PD-1+ lymphocytes associated with outcome in HER2+ breast cancer patients.
    Tsang JY; Au WL; Lo KY; Ni YB; Hlaing T; Hu J; Chan SK; Chan KF; Cheung SY; Tse GM
    Breast Cancer Res Treat; 2017 Feb; 162(1):19-30. PubMed ID: 28058578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.
    Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Breast; 2015 Oct; 24(5):667-72. PubMed ID: 26346586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
    Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
    Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.